| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00415-005-0020-Z |
| P698 | PubMed publication ID | 16541218 |
| P50 | author | Nicola De Stefano | Q56811273 |
| Placido Bramanti | Q59692852 | ||
| P2093 | author name string | Antonio Federico | |
| Silvia Marino | |||
| Antonio Giorgio | |||
| Marco Battaglini | |||
| Marzia Mortilla | |||
| Maria L Stromillo | |||
| Walter Borsini | |||
| Susanna Buchner | |||
| P2860 | cites work | Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene | Q24319125 |
| Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies | Q28304567 | ||
| Diffuse central neuronal involvement in Fabry disease: a proton MRS imaging study | Q28376243 | ||
| Measurement of atrophy in multiple sclerosis: pathological basis, methodological aspects and clinical relevance | Q30706224 | ||
| Accurate, robust, and automated longitudinal and cross-sectional brain change analysis | Q30755158 | ||
| Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability | Q31932002 | ||
| Axonal loss in multiple sclerosis lesions: magnetic resonance imaging insights into substrates of disability | Q33879542 | ||
| Nervous system involvement in Fabry's disease: clinicopathological and biochemical correlation | Q34685789 | ||
| Transient ischaemic attacks are associated with increased rates of global cerebral atrophy | Q35471302 | ||
| Magnetization transfer ratio of white matter hyperintensities in subcortical ischemic vascular dementia | Q35844425 | ||
| Pulsed magnetization transfer spin-echo MR imaging | Q36764300 | ||
| Cerebrovascular complications of Fabry's disease | Q36805657 | ||
| Imaging cerebral atrophy: normal ageing to Alzheimer's disease | Q40518545 | ||
| T1 hyperintensity in the pulvinar: key imaging feature for diagnosis of Fabry disease | Q43783655 | ||
| Axonal metabolic recovery in multiple sclerosis patients treated with interferon beta-1b. | Q43834552 | ||
| N-acetylaspartate is an axon-specific marker of mature white matter in vivo: a biochemical and immunohistochemical study on the rat optic nerve | Q43849057 | ||
| White matter lesions in Fabry disease occur in 'prior' selectively hypometabolic and hyperperfused brain regions | Q44708295 | ||
| Homocysteine, cerebrovascular disease and brain atrophy | Q45146707 | ||
| Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis | Q45742330 | ||
| Clinical features of and recent advances in therapy for Fabry disease | Q45872889 | ||
| CNS involvement in Fabry disease: clinical and imaging studies before and after 12 months of enzyme replacement therapy | Q47436803 | ||
| Magnetization transfer ratio in cerebral white matter lesions of Binswanger's disease | Q48119695 | ||
| Magnetization transfer: theory and clinical applications in neuroradiology | Q48159948 | ||
| Combined magnetization transfer and proton spectroscopic imaging in the assessment of pathologic brain lesions in multiple sclerosis. | Q48186536 | ||
| The proton NMR spectrum in acute EAE: the significance of the change in the Cho:Cr ratio | Q48274750 | ||
| Increased signal intensity in the pulvinar on T1-weighted images: a pathognomonic MR imaging sign of Fabry disease. | Q48277815 | ||
| Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease | Q48312235 | ||
| Quantitative analysis of cerebral vasculopathy in patients with Fabry disease | Q48444572 | ||
| Cognitive decline in AD and mild cognitive impairment is associated with global brain damage | Q48481240 | ||
| Cerebrovascular manifestations in a female carrier of Fabry's disease | Q48568620 | ||
| Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study | Q48619667 | ||
| Normalized accurate measurement of longitudinal brain change | Q48881982 | ||
| Abnormal magnetization transfer ratios in normal-appearing white matter on conventional MR images of patients with occlusive cerebrovascular disease. | Q48889260 | ||
| Correlations between clinical findings and magnetization transfer imaging metrics of tissue damage in individuals with cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy | Q48960204 | ||
| The clinical meaning of Rankin 'handicap' grades after stroke. | Q53636835 | ||
| Reversible decreases in N-acetylaspartate after acute brain injury | Q57043105 | ||
| A Magnetization Transfer Imaging Study of Normal-Appearing White Matter in Multiple Sclerosis | Q57912085 | ||
| Reversal of brain metabolic alterations with zidovudine detected by proton localised magnetic resonance spectroscopy | Q72355934 | ||
| Use of the brain parenchymal fraction to measure whole brain atrophy in relapsing-remitting MS. Multiple Sclerosis Collaborative Research Group | Q73187378 | ||
| Magnetization transfer imaging of traumatic brain injury | Q73453033 | ||
| Anderson-Fabry disease with cerebrovascular complications in two Italian families | Q74796797 | ||
| Anderson-Fabry disease: clinical manifestations of disease in female heterozygotes | Q77529217 | ||
| P433 | issue | 4 | |
| P921 | main subject | Fabry disease | Q615645 |
| P304 | page(s) | 434-440 | |
| P577 | publication date | 2006-03-20 | |
| P1433 | published in | Journal of Neurology | Q6295649 |
| P1476 | title | Diffuse structural and metabolic brain changes in Fabry disease | |
| P478 | volume | 253 |
| Q33998617 | CNS manifestations of Fabry's disease |
| Q36326940 | Detecting the effects of Fabry disease in the adult human brain with diffusion tensor imaging and fast bound-pool fraction imaging |
| Q57160819 | Development and clinical consequences of white matter lesions in Fabry disease: a systematic review |
| Q48223989 | Diffusion tensor imaging and brain volumetry in Fabry disease patients |
| Q35110216 | Fabry disease and early stroke |
| Q37113004 | Fibrosis: a key feature of Fabry disease with potential therapeutic implications |
| Q31028468 | In Vivo NMR Studies of the Brain with Hereditary or Acquired Metabolic Disorders |
| Q31117157 | Magnetization transfer magnetic resonance imaging of the brain, spinal cord, and optic nerve |
| Q58616419 | Neuroimaging in Fabry disease: current knowledge and future directions |
| Q36728591 | Neurological manifestations in Fabry's disease |
| Q42477832 | Quantitative in vivo brain magnetic resonance spectroscopic monitoring of neurological involvement in mucopolysaccharidosis type II (Hunter Syndrome). |
| Q34061632 | Stroke and Fabry disease. |
Search more.